A novel nanoparticle-based drug carrier for photodynamic therapy is reported which can provide stable aqueous dispersion of hydrophobic photosensitizers, yet preserve the key step of photogeneration of singlet oxygen, necessary for photodynamic action. A multidisciplinary approach is utilized which involves (i) nanochemistry in micellar cavity to produce these carriers, (ii) spectroscopy to confirm singlet oxygen production, and (iii) in vitro studies using tumor cells to investigate drug-carrier uptake and destruction of cancer cells by photodynamic action. Ultrafine organically modified silica-based nanoparticles (diameter approximately 30 nm), entrapping water-insoluble photosensitizing anticancer drug 2-devinyl-2-(1-hexyloxyethyl) pyropheophorbide, have been synthesized in the nonpolar core of micelles by hydrolysis of triethoxyvinylsilane. The resulting drug-doped nanoparticles are spherical, highly monodispersed, and stable in aqueous system. The entrapped drug is more fluorescent in aqueous medium than the free drug, permitting use of fluorescence bioimaging studies. Irradiation of the photosensitizing drug entrapped in nanoparticles with light of suitable wavelength results in efficient generation of singlet oxygen, which is made possible by the inherent porosity of the nanoparticles. In vitro studies have demonstrated the active uptake of drug-doped nanoparticles into the cytosol of tumor cells. Significant damage to such impregnated tumor cells was observed upon irradiation with light of wavelength 650 nm. Thus, the potential of using ceramic-based nanoparticles as drug carriers for photodynamic therapy has been demonstrated.
We report energy-transferring organically modified silica nanoparticles for two-photon photodynamic therapy. These nanoparticles co-encapsulate two-photon fluorescent dye nanoaggregates as an energy up-converting donor and a photosensitizing PDT drug as an acceptor. They combine two features: i) aggregation-enhanced two-photon absorption and emission properties of a novel two-photon dye, and ii) nanoscopic fluorescence resonance energy transfer between this nanoaggregate and a photosensitizer, 2-devinyl-2-(1-hexyloxyethyl)pyropheophorbide. Stable aqueous dispersions of the co-encapsulating nanoparticles (diameter≤30 nm) have been prepared in the nonpolar interior of micelles by co-precipitating an organically modified silica sol with the photosensitizer and an excess amount of the two-photon dye which forms fluorescent aggregates by phase separation from the particle matrix. Using a multidisciplinary nanophotonic approach, we show: i) indirect excitation of the photosensitizer through efficient two-photon excited intraparticle energy transfer from the dye aggregates in the intracellular environment of tumor cells, and ii) generation of singlet oxygen and in-vitro cytotoxic effect in tumor cells by photosensitization under two-photon irradiation.
A novel method for the synthesis of highly monodispersed hydrophillic InP-ZnS nanocrystals and their use as luminescence probes for live cell imaging is reported. Hydrophobic InP-ZnS nanocrystals are prepared by a new method that yields high-quality, luminescent core-shell nanocrystals within 6-8 h of total reaction time. Then by carefully manipulating the surface of these passivated nanocrystals, aqueous dispersions of folate-conjugated nanocrystals (folate-QDs) with high photostability are prepared. By use of confocal microscopy, we demonstrate the receptor-mediated delivery of folic acid conjugated quantum dots into folate-receptor-positive cell lines such as KB cells. These folate-QDs tend to accumulate in multi-vescicular bodies of KB cells after 6 h of incubation. Receptor-mediated delivery was confirmed by comparison with the uptake of these particles in folate-receptor-negative cell lines such as A549. Efficient two-photon excitation of these particles and two-photon imaging using these particles are also demonstrated. The use of these InP-ZnS nanoparticles and their efficient two-photon excitation can be potentially useful for deep tissue imaging for future in vivo studies.
Gold nanorods coated with multilayer polyelectrolyte is reported as a biocompatible optical probe with capability
for dark-field imaging and for electron microscopy of cancer cells. Transferrin (Tf) was conjugated to the
polyelectrolyte-coated nanorods for targeted in vitro delivery to cancer cells. Dark-field imaging was used to
confirm the receptor-mediated uptake of nanorods into HeLa cells, which is known to overexpress the transferrin
receptor (TfR). Minimal uptake was observed with untargeted nanorods. Electron microscopy was used to
confirm that the intracellular uptake of the nanorods predominantly occurred via the Tf−TfR interaction and
the nanorods localized in vesicular structures such as endosomes.
This paper reports the design, synthesis, and theoretical modeling of two‐photon properties of a new class of chromophore that exhibits enhanced two‐photon absorption (TPA) and subsequently generated strong up‐converted emission in nanoaggregate forms. This chromophore utilizes the basic structural unit of 9,10‐bis[4′‐(4″‐aminostyryl)styryl]anthracene that exhibits large internal rotation in the monomer form in organic solvents, whereby the fluorescence is greatly reduced. In nanoaggregates formed in water, the internal rotation is considerably hindered, leading to significant increases of TPA and fluorescence quantum yield. Theoretical modeling of the conformational structure and dynamics has utilized a semiempirical pm3 formalism. The TPA cross sections of the monomer and the aggregate states have been calculated on the basis of the quadratic response theory applied to a single‐determinant self‐consistent field reference state making use of a split‐valence 6‐31G* basis set.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.